RecruitingNCT06159699

Telecommunication Technology-based Online Survey

New Challenges for the Population on the Path to Achieving Active Longevity: an Online Survey of Respondents Using Telecommunication Technologies


Sponsor

Tomsk National Research Medical Center of the Russian Academy of Sciences

Enrollment

2,000 participants

Start Date

Dec 2, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

The aim of this study is to identify and assess new health-associated risk factors, including clinical-pharmacological risk factors. The cohort is built using telecommunication approaches. The associations between clinical-pharmacological, social, demographic, behavioral, and environmental characteristics will be assessed. The continuous depersonalized online survey is performed using the original informational resources in the form of specially designed web-site aimed at identification and assessment of population-based pharmacotherapy patterns including characteristics of self-medication, biologically active food supplement intake, polypharmacy, and adverse drug-drug interactions in the people residing in the ecological conditions of various regions of the country. The invitations to participate in the online survey are sent via the SMS messages using the SMS-Target tool provided by OOO T2 Mobile Company. The survey is performed online at www.zdorov.tpu.ru and www.zdorov.expert both specifically designed for questionnaire publication and data accumulation.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • age of 18 years and older
  • signing the informed concent form online
  • completion of the entire questionnaire

Exclusion Criteria2

  • age under 18 years
  • refuse to sign the informed concent form

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHEROnline Survey

The participants of the study undergo the online survey at www.zdorov.tpu.ru and www.zdorov.expert.

DIAGNOSTIC_TESTGenetic Testing

Genetic testing will be performed in subgroup of survey respondents willing to participate in the study of polymorphisms of genes involved in drug metabolism or affecting biological effects of medications including CYP2D6, ACE, UGT1A1, CYP2C9, and CYP2C19.


Locations(1)

Tomsk National Research Medical Center, Russian Academy of Sciences

Tomsk, Russia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06159699


Related Trials